Analyzing...
Loading company...
Nureca Ltd. design and manufactures health monitoring devices. The company is headquartered in Mumbai, Maharashtra and currently employs 102 full-time employees. The company went IPO on 2021-02-25. The main products/services that the Company manufactures include chronic disease products, orthopedic products, mother and child products, nutrition supplements, lifestyle products, and connected devices. Its chronic disease products include nebulizers, BP monitors, finger pulse oximeters, glucose meters and thermometers. Its orthopedic products include wheelchairs, walkers, lumbar and tailbone supports and physiotherapy electric massagers. Its mother and babycare products include baby feeding, carry cots, baby skincare, nebulizers and bottle warmers and steamers. Its nutrition supplements include supplements and weight management products. Its lifestyle products include humidifiers and steamers, personal scales, massagers, fitness tracking, and dental and personal care. The firm's products are offered through its brands, such as Dr Trust, Dr Physio, and Trumom.
Excluded by gate
Nothing flagged for monitoring
“Operates in Healthcare — Equipment & Devices.”
₹147 Cr revenue.
COGS 63.1%, employees 11.6%.
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 1.1%▼ | 8.6% |
| ROCE | 3.4%▼ | 12.6% |
| Net Margin | 1.3%▼ | 8.2% |
| EBITDA Margin | 5.3%▼ | 15.6% |
| Debt To Equity | 0.00x▼ | 0.11x |
| Rev Growth 3yr | 9.4%▼ | 14.8% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹147 Cr +34.0% | ₹110 Cr +19.3% | ₹92 Cr -17.4% | ₹111 Cr -56.4% | ₹256 Cr +19.7% | ₹213 Cr |
| Other Income | ₹8 Cr -34.9% | ₹12 Cr +18.3% | ₹11 Cr +48.0% | ₹7 Cr -7.7% | ₹8 Cr +173.2% | ₹3 Cr |
| Total Income | ₹155 Cr +27.0% | ₹122 Cr +19.2% | ₹102 Cr -13.5% | ₹118 Cr -55.0% | ₹263 Cr +21.7% | ₹216 Cr |
| COGS | ₹93 Cr +36.3% | ₹68 Cr +12.2% | ₹61 Cr -19.7% | ₹76 Cr -43.0% | ₹133 Cr +33.3% | ₹99 Cr |
| ₹150 Cr +24.3% | ₹121 Cr +15.0% | ₹105 Cr -18.7% | ₹129 Cr -36.1% | ₹202 Cr +31.4% | ₹154 Cr | |
| Profit Before Tax | ₹5 Cr +270.7% | ₹1 Cr ↑ Recovery | (₹3 Cr) +76.3% | (₹11 Cr) ↓ Decline | ₹61 Cr -2.2% | ₹62 Cr |
| ₹3 Cr +483.1% | ₹0.50 Cr ↑ Recovery | (₹0.75 Cr) +69.9% | (₹2 Cr) ↓ Decline | ₹16 Cr +0.4% | ₹16 Cr | |
| Net Profit | ₹2 Cr +146.0% | ₹0.85 Cr ↑ Recovery | (₹2 Cr) +78.3% | (₹8 Cr) ↓ Decline | ₹45 Cr -3.0% | ₹46 Cr |
| Profit (Owners) | ₹2 Cr +146.0% | ₹0.85 Cr ↑ Recovery | (₹2 Cr) +78.3% | (₹8 Cr) ↓ Decline | ₹45 Cr -3.0% | ₹46 Cr |
| Other Comprehensive Income | ₹0.07 Cr -77.1% | ₹0.33 Cr | ₹0.02 Cr ↑ Recovery | (₹0.07 Cr) ↓ Decline | ₹0.14 Cr | ₹0.01 Cr |
| EPS | ₹1.79 | ₹0.85 | (₹1.79) | (₹8.25) | ₹44.96 | ₹46.37 |
| Diluted Shares | ₹0.95 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| Profit Loss From Discontinued Operations After Tax | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
No earnings call transcripts available.
Nureca Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 28, 2026. Further, the company has informed the Exchange regarding voting results.
Nureca Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 28, 2026
Nureca Limited has informed the Exchange about Copy of Newspaper Publication
Nureca Limited has informed the Exchange regarding 'Investor Presentation for Q1 & FY'27'.
Nureca Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Nureca Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Nureca Limited has informed the Exchange regarding 'Resubmission of a More Legible Copy of the Notice of 10th Annual General Meeting ( AGM ) and Annual Report 2025-26 submitted on 03 July 2026'.
Saurabh Goyal has submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulat...
Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Nureca Limited has informed the Exchange regarding a press release dated Jun 20, 2026, titled "Dr Trust 360 Crosses 2.4 Million Users;Launches Advanced AI Health Analytics ".
Nureca Limited has informed the Exchange about Agreements
Nureca Limited has informed the Exchange regarding 'Intimation regarding no change in the aggregate shareholding of the Promoter and Promoter Group of the Company pursuant to Inter Se Transfer of Shar...
Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015( PIT Regulations )'.
Nureca Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015( PIT Regulations )'.
Nureca Limited has informed the Exchange regarding Re-Appointment of MGSG AND ASSOCIATES as Internal Auditor of the company w.e.f. April 01, 2026.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.